In vitro diagnostic testing for antibiotic allergy

Allergy, Asthma and Immunology Research

Volumn 9, Issue 4, 2017, Pages 288-298

  Doña, Inmaculada ^a   Torres, Maria J ^a,b   Montañez, Maria I ^a,b   Fernández, Tahía D ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

Antibiotic; Drug allergy; In vitro test

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; GLYCOPEPTIDE; QUINOLONE DERIVATIVE; SULFONAMIDE;

ARTICLE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; HISTAMINE RELEASE; HUMAN; IMMUNOASSAY; IN VITRO STUDY; LYMPHOCYTE TRANSFORMATION TEST; SKIN TEST;

EID: 85019186120     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2017.9.4.288     Document Type: Article

References (74)

1. Romano A, Warrington R. Antibiotic allergy. Immunol Allergy Clin North Am 2014;34:489-506.
2. Torres MJ, Montañez MI, Ariza A, Salas M, Fernandez TD, Barbero N, et al. The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid. Clin Exp Allergy 2016;46:264-74.
3. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014;14: 742-50.
4. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16.
5. Doña I, Blanca-López N, Torres MJ, García-Campos J, García-Núñez I, Gómez F, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012;22:363-71.
6. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011;127:S67-73.
7. Torres MJ, Salas M, Ariza A, Fernández TD. Understanding the mechanisms in accelerated drug reactions. Curr Opin Allergy Clin Immunol 2016;16:308-14.
8. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-93.
9. Blanca M, Mayorga C, Torres MJ, Warrington R, Romano A, Demoly P, et al. Side-chainspecific reactions to betalactams: 14 years later. Clin Exp Allergy 2002;32:192-7.
10. Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010;94:805-20.
11. Romano A, Piunti E, Di Fonso M, Viola M, Venuti A, Venemalm L. Selective immediate hypersensitivity to ceftriaxone. Allergy 2000; 55:415-6.
12. Torres MJ, Ariza A, Mayorga C, Doña I, Blanca-Lopez N, Rondon C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010;125:502-505.e2.
13. Aranda A, Mayorga C, Ariza A, Doña I, Rosado A, Blanca-Lopez N, et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011;66:247-54.
14. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and crossreactivity. Clin Exp Allergy 2006;36:59-69.
15. Blanca-López N, Ariza A, Doña I, Mayorga C, Montañez MI, Garcia-Campos J, et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy 2013;43:560-7.
16. Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548-59.
17. Schnyder B, Pichler WJ. Allergy to sulfonamides. J Allergy Clin Immunol 2013;131:256-257.e1-5.
18. Anne' S, Middleton E Jr, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994;73:402-4.
19. Bernedo N, González I, Gastaminza G, Audicana M, Fernández E, Muñoz D. Positive patch test in vancomycin allergy. Contact Dermat 2001;45:43.
20. Sharif S, Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidinlinked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol 2007;98:563-6.
21. Connolly M, McAdoo J, Bourke JF. Gentamicininduced anaphylaxis. Ir J Med Sci 2007;176:317-8.
22. Araújo L, Demoly P. Macrolides allergy. Curr Pharm Des 2008;14: 2840-62.
23. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998;37:833-8.
24. Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med 1997; 157:1421-8.
25. Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, et al. Minocyclineinduced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009; 145:63-6.
26. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study. J Allergy Clin Immunol 2014;133:790-6.
27. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999;54:999-1003.
28. Torres MJ, Mayorga C, Leyva L, Guzman AE, Cornejo-García JA, Juarez C, et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002;32:270-6.
29. Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009;64:183-93.
30. Fernández TD, Ariza A, Palomares F, Montañez MI, Salas M, MartínSerrano A, et al. Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone. Medicine (Baltimore) 2016; 95:e3679.
31. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63.
32. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2016;71:1103-34.
33. Blanca M, Mayorga C, Torres MJ, Reche M, Moya MC, Rodriguez JL, et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001;56:862-70.
34. Garcia JJ, Blanca M, Moreno F, Vega JM, Mayorga C, Fernandez J, et al. Determination of IgE antibodies to the benzylpenicilloyl determinant: a comparison of the sensitivity and specificity of three radio allergo sorbent test methods. J Clin Lab Anal 1997;11:251-7.
35. Fontaine C, Mayorga C, Bousquet PJ, Arnoux B, Torres MJ, Blanca M, et al. Relevance of the determination of serumspecific IgE antibodies in the diagnosis of immediate ß-lactam allergy. Allergy 2007;62:47-52.
36. Montañez MI, Perez-Inestrosa E, Suau R, Mayorga C, Torres MJ, Blanca M. Dendrimerized cellulose as a scaffold for artificial antigens with applications in drug allergy diagnosis. Biomacromolecules 2008;9:1461-6.
37. Vida Y, Montañez MI, Collado D, Najera F, Ariza A, Blanca M, et al. Dendrimeric antigensilica particle composites: an innovative approach for IgE quantification. J Mater Chem B Mater Biol Med 2013;1:3044-50.
38. Mayorga C, Perez-Inestrosa E, Molina N, Montañez MI. Development of nanostructures in the diagnosis of drug hypersensitivity reactions. Curr Opin Allergy Clin Immunol 2016;16:300-7.
39. Montañez MI, Mayorga C, Torres MJ, Blanca M, Perez-Inestrosa E. Methodologies to anchor dendrimeric nanoconjugates to solid phase: toward an efficient in vitro detection of allergy to ß-lactam antibiotics. Nanomedicine 2011;7:682-5.
40. Ruiz-Sanchez AJ, Montañez MI, Mayorga C, Torres MJ, Kehr NS, Vida Y, et al. Dendrimer-modified solid supports: nanostructured materials with potential drug allergy diagnostic applications. Curr Med Chem 2012;19:4942-54.
41. Romano A, Guéant Rodriguez RM, Viola M, Amoghly F, Gaeta F, Nicolas JP, et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005;35:1234-42.
42. Soler M, Mesa-Antunez P, Estevez MC, Ruiz-Sanchez AJ, Otte MA, Sepulveda B, et al. Highly sensitive dendrimer-based nanoplasmonic biosensor for drug allergy diagnosis. Biosens Bioelectron 2015;66:115-23.
43. Fernández TD, Torres MJ, Blanca-López N, Rodríguez-Bada JL, Gomez E, Canto G, et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009;64:242-8.
44. Sanz ML, Gamboa PM, Antépara I, Uasuf C, Vila L, GarciaAvilés C, et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002;32:277-86.
45. Johansson SG, Adédoyin J, van Hage M, Grönneberg R, Nopp A. False-positive penicillin immunoassay: an unnoticed common problem. J Allergy Clin Immunol 2013;132:235-7.
46. Vultaggio A, Matucci A, Virgili G, Rossi O, Filì L, Parronchi P, et al. Influence of total serum IgE levels on the in vitro detection of betalactams-specific IgE antibodies. Clin Exp Allergy 2009;39:838-44.
47. Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A. High serum ß-lactams specific/total IgE ratio is associated with immediate reactions to ß-lactams antibiotics. PLoS One 2015;10: e0121857.
48. Manfredi M, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004;113:155-60.
49. Ariza A, Montañez MI, Fernández TD, Perkins JR, Mayorga C. Cellular tests for the evaluation of drug hypersensitivity. Curr Pharm Des. 2016;22(45):6773-83.
50. Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy 2015;70:1393-405.
51. De Week AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 2008;18:143-55.
52. Ghannadan M, Hauswirth AW, Schernthaner GH, Müller MR, Klepetko W, Schatzl G, et al. Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol 2002;127:299-307.
53. Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, et al. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008;38:921-8.
54. Torres MJ, Padial A, Mayorga C, Fernández T, Sanchez-Sabate E, Cornejo-García JA, et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004;34:1768-75.
55. De Week AL, Sanz ML, Gamboa PM, Aberer W, Sturm G, Bilo MB, et al. Diagnosis of immediatetype beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. J Investig Allergol Clin Immunol 2009;19:91-109.
56. Torres MJ, Romano A, Blanca-Lopez N, Doña I, Canto G, Ariza A, et al. Immunoglobulin E-mediated hypersensitivity to amoxicillin: in vivo and in vitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy 2011;41:1595-601.
57. Torres MJ, Ariza A, Fernández J, Moreno E, Laguna JJ, Montañez MI, et al. Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy 2010;65: 5906.
58. Rouzaire P, Nosbaum A, Denis L, Bienvenu F, Bérard F, Cozon G, et al. Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decisionmaking. Int Arch Allergy Immunol 2012;157:299-302.
59. Ben Said B, Berard F, Bienvenu J, Nicolas JF, Rozieres A. Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy 2010;65:535-6.
60. Mayorga C, Andreu I, Aranda A, Doña I, Montañez MI, Blanca-Lopez N, et al. Fluoroquinolone photodegradation influences specific basophil activation. Int Arch Allergy Immunol 2013;160:377-82.
61. Harrabi S, Loiseau P, Dehenry J. A technic for human basophil degranulation. Allerg Immunol (Paris) 1987;19:287-9.
62. Ebo DG, Verheecke G, Bridts CH, Mertens CH, Stevens WJ. Perioperative anaphylaxis from locally applied rifamycin SV and latex. Br J Anaesth 2006;96:738-41.
63. Pineda F, Ariza A, Mayorga C, Arribas F, GonzálezMendiola R, Blanca-López N, et al. Role of histamine release test for the evaluation of patients with immediate hypersensitivity reactions to clavulanic acid. Int Arch Allergy Immunol 2015;168:233-40.
64. Kleine Budde I, de Heer PG, van der Zee JS, Aalberse RC. The stripped basophil histamine release bioassay as a tool for the detection of allergenspecific IgE in serum. Int Arch Allergy Immunol 2001;126:277-85.
65. Porebski G, PecaricPetkovic T, Groux-Keller M, Bosak M, Kawabata TT, Pichler WJ. In vitro drug causality assessment in Stevens-Johnson syndrome-alternatives for lymphocyte transformation test. Clin Exp Allergy 2013;43:1027-37.
66. Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007;62:1439-44.
67. Polak ME, Belgi G, McGuire C, Pickard C, Healy E, Friedmann PS, et al. In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. Br J Dermatol 2013; 168:539-49.
68. Luque I, Leyva L, José Torres M, Rosal M, Mayorga C, Segura JM, et al. In vitro Tcell responses to betalactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56:611-8.
69. Rodriguez-Pena R, Lopez S, Mayorga C, Antunez C, Fernandez TD, Torres MJ, et al. Potential involvement of dendritic cells in delayedtype hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006;118:949-56.
70. Sanchez-Quintero MJ, Torres MJ, Blazquez AB, Gómez E, Fernandez TD, Doña I, et al. Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients. PLoS One 2013;8:e74198.
71. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005;5:15-21.
72. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003;3:275-81.
73. Kalish RS, LaPorte A, Wood JA, Johnson KL. Sulfonamidereactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 1994;94:465-72.
74. Fu M, Gao Y, Pan Y, Li W, Liao W, Wang G, et al. Recovered patients with StevensJohson syndrome and toxic epidermal necrolysis maintain longlived IFN-gamma and sFasL memory response. PLoS One 2012;7:e45516.